Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia

Clinical Immunology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles